Myocardial Perfusion SPECT 2024 in Germany: Results of the 10th Survey

Oliver Lindner; Matthias Gutberlet; Wolfgang Burchert; Thorsten Derlin; Christoph Rischpler

doi:10.1055/a-2738-2589

Nuklearmedizin - NuclearMedicine, Table of Contents

Nuklearmedizin
DOI: 10.1055/a-2738-2589

Original Article

Myocardial Perfusion SPECT 2024 in Germany: Results of the 10th Survey

Myokard-Perfusions-SPECT 2024 in Deutschland: Ergebnisse der 10. Erhebung

Authors

Oliver Lindner

¹Institute of Radiology, Nuclearmedicine and Molecular Imaging, Heart and Diabetes Center North Rhine-Westphalia, Bad Oeynhausen, Germany
Matthias Gutberlet

²Department of Radiology, Leipzig Heart Centre University Hospital, Leipzig, Germany (Ringgold ID: RIN40628)
Wolfgang Burchert

¹Institute of Radiology, Nuclearmedicine and Molecular Imaging, Heart and Diabetes Center North Rhine-Westphalia, Bad Oeynhausen, Germany
Thorsten Derlin

¹Institute of Radiology, Nuclearmedicine and Molecular Imaging, Heart and Diabetes Center North Rhine-Westphalia, Bad Oeynhausen, Germany
Christoph Rischpler

³Clinic for Nuclear Medicine, City of Stuttgart Hospitals Katharinenhospital, Stuttgart, Germany (Ringgold ID: RIN9203)

Abstract

Aim

This paper presents the results of the 10^th survey of myocardial perfusion SPECT (MPS) from the year 2024.

Methods

A total of 198 questionnaires were evaluated, comprising 115 practices (PR), 57 hospitals (HO) and 26 university hospitals (UH). The results of the previous survey 2021 are shown in squared brackets.

Results

MPS data from 128.707 [133.057] patients (–3.3%) with 125.175 [131.868] stress and 102.903 [106.546] rest MPS were analysed. A comparison with official data revealed that 53% of all MPS were recorded. From 2018 to 2024, official data showed an increase in MPS every year. In 2024, on average, 650 [610] MPS patients (+7%) were examined in each department. Of the participating departments, 69% [74%] reported an increase or no changes in their patient numbers. As always ambulatory care cardiologists represented the major referral group (68% [69%]). Pharmacological stress was performed more frequently than ergometry (43% [42%]). Regadenoson was mostly used. The use of the different protocols remained almost unchanged. Two-day protocols were predominantly applied (49% [49%]). Multi-head cameras were used in (56% [58%] of the departments and SPECT-CT systems in (31% [28%]). Attenuation correction was performed in 35% [33%] of all MPS. 95% [89%] of all stress, 93% [88%] of all rest and 92% [87%] of all stress and rest scan were acquired as gated SPECT. 84% [72%] of the departments performed scoring by default. The proportion of departments not scoring decreased to 4% [13%].

Conclusions

The MPS 2024 survey indicates that the long-term positive development of MPS imaging is continuing. The procedural and technical details of MPS imaging demonstrate a high level of conformity with guidelines, with a slight improvement observed from 2021 to 2024.

Keywords

Myocardial perfusion SPECT - utilization review - utilization statistics - numerical data - ATTR imaging

Full Text

References

References
1 Lindner O, Burchert W, Bengel FM. et al. Myocardial perfusion scintigraphy in Germany. Results of the 2005 query and current status. Nuklearmedizin 2007; 46: 49-55
2 Lindner O, Burchert W, Bengel FM. et al. Myocardial perfusion scintigraphy 2006 in Germany. Results of the query and current status. Nuklearmedizin 2008; 47: 139-145
3 Lindner O, Burchert W, Bengel FM. et al. Myocardial perfusion scintigraphy 2007 in Germany--results of the query and current status. Nuklearmedizin 2009; 48: 131-137
4 Lindner O, Burchert W, Bengel FM. et al. Myocardial perfusion scintigraphy 2008 in Germany – results of the fourth query. Nuklearmedizin 2010; 49: 65-72
5 Lindner O, Burchert W, Bengel FM. et al. Myocardial perfusion scintigraphy in Germany in 2009: utilization and state of the practice. Eur J Nucl Med Mol Imaging 2011; 38: 1485-1492
6 Lindner O, Burchert W, Buechel R. et al. Myocardial Perfusion SPECT 2018 in Germany: Results of the 8th Survey. Nuklearmedizin 2019; 58: 425-433
7 Lindner O, Burchert W, Schafer W. et al. Myocardial perfusion SPECT 2015 in Germany. Results of the 7(th) survey. Nuklearmedizin 2017; 56: 31-38
8 Lindner O, Burchert W, Schafers M. et al. Myocardial perfusion scintigraphy 2012 in Germany. Results of the 6th Query. Nuklearmedizin 2014; 53: 13-18
9 Lindner O, Schaefer WM, Silber S. et al. Myocardial Perfusion SPECT and ATTR imaging 2021 in Germany: Results of the 9th Survey. Nuklearmedizin 2023; 62: 235-243
10 Lindner O, Bucerius J, Burchert W. et al. Scintigraphy for Transthyretin Cardiac Amyloidosis Diagnosis in Austria, Germany, and Switzerland from 2021 to 2024. A Survey Report. Eur J Nucl Med Mol Imaging 2025;
11 (DESTASIS) SB. Sozialleistungen – Angaben zur Krankenversicherung 2019 (Ergebnisse des Mikrozensus). Accessed September 25, 2025 at: www.destatis.de/DE/Themen/Gesellschaft-Umwelt/Gesundheit/Gesundheitszustand-Relevantes-Verhalten/Publikationen/Downloads-Gesundheitszustand/krankenversicherung-mikrozensus-2130110199004.pdf?__blob=publicationFile
12 Single photon emission computed tomography for the diagnosis of coronary artery disease: an evidence-based analysis. Ont Health Technol Assess Ser 2010; 10: 1-64
13 Huxohl T, Patel G, Zabel R. et al. Deep learning approximation of attenuation maps for myocardial perfusion SPECT with an IQ SPECT collimator. EJNMMI Phys 2023; 10: 49
14 Lindner O. (Koordinierender Autor), Nuklearmedizin DGN. S1-Leitlinie Myokard-Perfusions-SPECT(-CT). 2022. AWMF Registernummer 031–006.. 2022
15 Verberne HJ, Acampa W, Anagnostopoulos C. et al. EANM procedural guidelines for radionuclide myocardial perfusion imaging with SPECT and SPECT/CT: 2015 revision. Eur J Nucl Med Mol Imaging 2015; 42: 1929-1940
16 Lindner O, Bengel FM, Hacker M. et al. Use of myocardial perfusion imaging and estimation of associated radiation doses in Germany from 2005 to 2012. Eur J Nucl Med Mol Imaging 2014; 41: 963-971